TRA-934: INCORPORATION OF ROUNDABOUTS AT HOLT RD INTERCHANGE

The planned refurbishment of the Darlington Nuclear Generating Station (DNGS) by the Ontario Power Generation (OPG), scheduled to commence in late-2016 and extend until 2026, will result in significant employment growth and increased traffic volumes that cannot be supported by the area’s roadway network. In particular, the original Highway 401/Holt Road interchange, located approximately 40 km east of Toronto and serving as the primary access route for employee traffic into and out of the DNGS, was in need of significant upgrade and improvement in advance of commencing the refurbishment. The original interchange provided partial access to the highway only, while an intersection between an adjacent service road and the eastbound off-ramp was considered both unconventional and potentially hazardous to drivers unfamiliar with the unique configuration. Further, the original Holt Road underpass structure precluded the necessary capacity additions required along both the crossing road and Highway 401 through the interchange. Consequently, the Ontario Ministry of Transportation (MTO) hired AECOM to provide Preliminary and Detail Design services for upgrading of the Highway 401/Holt Road interchange to address both the existing concerns and meet the future requirements of the area. The recommended design included provision of roundabouts at both the north and south ramp terminals, and a third successive multi-lane roundabout at a service road directly south of the interchange. The provision of roundabouts at freeway ramp terminals, in place of traffic signals, represents the first time such a design has been used on an MTO facility

Development and Application of a Camper Growth Index (CGI-C)

Many people know about the value of organized camp experiences for youth, but few instruments measure camp experiences relative to positive youth development. Over the past century, most studies have found positive outcomes on a variety of dimensions, but these studies have used mainly convenience nonrandornized samples, different criteria, and a variety of instruments in their assessments. The purpose of this paper is to present evidence about the psychometric properties of a scale specifically designed to measure youth development outcomes through camp experiences

Histone Modifications within the Human X Centromere Region

Human centromeres are multi-megabase regions of highly ordered arrays of alpha satellite DNA that are separated from chromosome arms by unordered alpha satellite monomers and other repetitive elements. Complexities in assembling such large repetitive regions have limited detailed studies of centromeric chromatin organization. However, a genomic map of the human X centromere has provided new opportunities to explore genomic architecture of a complex locus. We used ChIP to examine the distribution of modified histones within centromere regions of multiple X chromosomes. Methylation of H3 at lysine 4 coincided with DXZ1 higher order alpha satellite, the site of CENP-A localization. Heterochromatic histone modifications were distributed across the 400–500 kb pericentromeric regions. The large arrays of alpha satellite and gamma satellite DNA were enriched for both euchromatic and heterochromatic modifications, implying that some pericentromeric repeats have multiple chromatin characteristics. Partial truncation of the X centromere resulted in reduction in the size of the CENP-A/Cenp-A domain and increased heterochromatic modifications in the flanking pericentromere. Although the deletion removed ∼1/3 of centromeric DNA, the ratio of CENP-A to alpha satellite array size was maintained in the same proportion, suggesting that a limited, but defined linear region of the centromeric DNA is necessary for kinetochore assembly. Our results indicate that the human X centromere contains multiple types of chromatin, is organized similarly to smaller eukaryotic centromeres, and responds to structural changes by expanding or contracting domains

Using inferred residue contacts to distinguish between correct and incorrect protein models

Motivation: The de novo prediction of 3D protein structure is enjoying a period of dramatic improvements. Often, a remaining difficulty is to select the model closest to the true structure from a group of low-energy candidates. To what extent can inter-residue contact predictions from multiple sequence alignments, information which is orthogonal to that used in most structure prediction algorithms, be used to identify those models most similar to the native protein structure

Taxonomy based on science is necessary for global conservation

Peer reviewe

Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570

The driving forces underlying the formation of chiral domains of fluorinated diacids on graphite

The role of intermolecular interactions, molecule-substrate interactions and molecular chirality in the construction of 2-D surface architectures is the subject of much current interest. A racemic mixture of long chain hydrocarbons was synthesized with terminal carboxylic acid functionalities at each end, two amide linkages in the central region of the molecule either side of two F-containing chiral centres. Using Scanning Tunnelling Microscopy (STM), we have examined how the functionality of these molecules influences their self-assembly on an HOPG surface. The key factors determining the nature of ordered domains have been identified

Correction: A novel chemotactic factor derived from the extracellular matrix protein decorin recruits mesenchymal stromal cells in vitro and in vivo.

[This corrects the article DOI: 10.1371/journal.pone.0235784.]

A novel chemotactic factor derived from the extracellular matrix protein decorin recruits mesenchymal stromal cells in vitro and in vivo.

Soft tissue is composed of cells surrounded by an extracellular matrix that is made up of a diverse array of intricately organized proteins. These distinct components work in concert to maintain homeostasis and respond to tissue damage. During tissue repair, extracellular matrix proteins and their degradation products are known to influence physiological processes such as angiogenesis and inflammation. In this study we developed a discovery platform using a decellularized extracellular matrix biomaterial to identify new chemotrophic factors derived from the extracellular matrix. An in vitro culture of RAW.264 macrophage cells with the biomaterial ovine forestomach matrix led to the identification of a novel ~12 kDa chemotactic factor, termed 'MayDay', derived from the N-terminal 31-188 sequence of decorin. The recombinant MayDay protein was shown to be a chemotactic agent for mesenchymal stromal cells in vitro and in vivo. We hypothesize that the macrophage-induced cleavage of decorin, via MMP-12, leads to the release of the chemotactic molecule MayDay, that in turn recruits cells to the site of damaged tissue